Poster session details are as follows: Date: Thursday, May 16, 2024 Time: 12:00 – 1:00 p.m. CET/ 6:00 – 7:00 a.m. ET Category: Metastatic Breast Cancer
The reminders are everywhere. When a woman turns 40, doctors say she should begin receiving yearly mammograms to detect breast cancer. You see it on posters, ads and buttons.
The Canadian Cancer Society (CCS) is urging all provinces and territories to begin breast cancer screening at age 40 for those at average risk of the disease.
Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This research could ultimately help predict…
When you think about obesity, you may not connect it to cancer. However, researchers long have suspected a link between certain cancers and weight. Among those are endometrial, ovarian, colon, liver, pancreatic and postmenopausal breast…
Enveric Biosciences (NASDAQ:ENVB), a Nasdaq-listed psychedelics biotech firm, has entered into a non-binding term sheet with an undisclosed biotech company (licensee) for an exclusive license to two patented methods aimed at treating…
SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (("Olema" or "Olema Oncology, NASDAQ:OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted…
Researchers used a breast cancer cell line panel and primary tumor explants from breast and cervical cancer patients to examine two different cellular contractility modes: one that generates collective tissue surface tension that keeps…
Some of the final work of a late University of Virginia School of Medicine scientist has opened the door for life-saving new treatments for solid cancer tumors, including breast cancer, lung cancer and melanoma.
The anti-cancer drug abemaciclib (also known as Vernezio) has been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer.
CoppaFeel! founder Kris Hallenga, has died aged 38 after she was diagnosed with breast cancer when she was 23. She encouraged women to check their breasts for signs of cancer.